New facility offers genetic testing, counselling and personalised treatment plans to enable early diagnosis and precision-led care
Shares issued under ESOP 2008 and MESOP 2018 plans following exercise of vested stock options, in compliance with SEBI disclosure norms
Extending production capabilities to the Americas helps reduce labor costs and inventory complexity for nutraceuticals and other industries while maintaining superior moisture control
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
Veteran pharma leader brings 33+ years of experience to drive operational excellence in formulation business
Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence
Aims to boost speed & precision in patient care
New formulation by Greenspace Herbs to target improved efficacy and lower dosage in curcumin supplements
The move reinforces Croda’s push to fuel growth through high-impact innovation across its Consumer Care portfolio
With a PhD in Biochemistry and an executive MBA, she brings nearly two decades of experience in the in vitro diagnostics (IVD) sector
Subscribe To Our Newsletter & Stay Updated
